Table 1

Data extraction form

Study ID
Title
Author
Country of study conductUSA
UK
Canada
Australia
Other
Study characteristics
Aim
DesignRCT
Non-randomised experimental study
Cohort study
Cross-sectional study
Case–control study
Systematic review
Qualitative study
Prevalence study
Case series
Case report
Diagnostic test accuracy study
Clinical prediction rule
Economic evaluation
Text and opinion
Other
Start date
End date
Funding source
Conflict of interest
Participant characteristics
Population description
Inclusion criteria
Exclusion criteria
Sample size (n)
Birth weight (g)
Gestational age (week)
Postnatal age (week)
Underlying condition
Comorbidities
Concurrent medications
Intervention/exposure details
Paracetamol dosing regimen (mg/kg/dose)
Paracetamol duration (days)
Paracetamol route of administration
Control details
PharmacotherapySedative-analgesic
Epidural
NSAID
Other
Non-specified standard treatment
Outcomes
Primary outcomes
Long-term adverse effects
Neurodevelopmental adverse events
Atopic disorders
Reproductive disorders
Others
Secondary outcomes
Pharmacokinetic data
Pharmacodynamic data
Short-term adverse events
Increased hepatic transaminases
Gastrointestinal haemorrhage
Necrotising enterocolitis
Feeding intolerance
  • IQ, intelligence quotient; NSAID, non-steroidal anti-inflammatory drug; RCT, randomised controlled trial.